Tarek S Mansour

This inventor holds 17 USPTO granted patents and 2 published patent applications. Top assignees: Biochem Pharma Inc., Biochem Therapeutics Incorporated, Shire Biochem, Inc.. Active years: 1995-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tarek S Mansour. Retrieved from https://idiyas.com/inventor/tarek-s-mansour

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 94.1

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 347(Granted Patents)

Company Filing History:

Biochem Therapeutics Incorporated

Years Active: 1995-2004

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6831174 - Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties (2004-12-14),

2. 6369066 - Substituted 1,3-oxathiolanes with antiviral properties (2002-04-09),

3. 6228860 - Substituted 1,3-oxathiolanes with antiviral properties (2001-05-08),

4. 6175008 - Processes for preparing substituted 1,3-oxathiolanes with antiviral properties (2001-01-16),

5. 6156737 - Use of dideoxy nucleoside analogues in the treatment of viral infections (2000-12-05),

6. 6069250 - Method and compositions for the synthesis of dioxolane nucleosides with (2000-05-30),

7. 5945431 - Cytomegalovirus inhibiting compounds (1999-08-31),

8. 5922867 - Method and compositions for the synthesis of dioxolane nucleosides with (1999-07-13),

9. 5763606 - Stereoselective synthesis of nucleoside analogues using bicyclic (1998-06-09),

10. 5756706 - Processes for the diastereoselective synthesis of nucleoside analogues (1998-05-26),

11. 5744596 - Nucleoside analogues and synthetic intermediates (1998-04-28),

12. 5696254 - Processes for the diastereoselective synthesis of nucleoside analogues (1997-12-09),

13. 5693787 - Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside (1997-12-02),

14. 5684164 - Processes for preparing substituted 1,3-oxathiolanes with antiviral (1997-11-04),

15. 5663320 - Processes for the diastereoselective separation of nucleoside analogue (1997-09-02),

Title: The Innovative Contributions of Tarek S. Mansour

Introduction

Tarek S. Mansour is a prominent inventor based in Montreal, Canada, recognized for his significant contributions to the field of antiviral research. With an impressive portfolio of 17 patents, he has made considerable advancements that have the potential to impact the healthcare industry profoundly.

Latest Patents

Among his latest innovations are patents related to processes for preparing substituted 1,3-oxathiolanes, which exhibit unique antiviral properties. These inventions highlight his focus on developing compounds that could serve as crucial tools in combating viral infections.

Career Highlights

Throughout his career, Tarek has worked with notable organizations such as Biochem Pharma Inc. and Biochem Therapeutics Incorporated. His experience in these companies has allowed him to refine his expertise in pharmaceutical sciences and contribute to pioneering research initiatives in antiviral treatments.

Collaborations

Tarek has collaborated with esteemed colleagues, including Haolun Jin and Allan H. Tse, who have shared his vision for innovation in the pharmaceutical industry. Their combined efforts have been instrumental in fostering a creative and productive research environment.

Conclusion

In summary, Tarek S. Mansour's work exemplifies the spirit of innovation and dedication to advancing healthcare through science. His numerous patents and collaborative efforts showcase his commitment to improving human health and fighting viral diseases.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents pending: